Physician profile
Steven Larry Davis
NPI 1811120918
$348,701.77
in general payments reported to CMS, 2019-2025
10 companies · $79K in 2025
The $79K reported for 2025 was more than what 99% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $23K · 2021: $25K · 2022: $42K · 2023: $51K · 2024: $102K · 2025: $79K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $204K · Travel and Lodging: $22K · Food and Beverage: $6,615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $203,756.80 |
| Travel and Lodging | $21,820.29 |
| Food and Beverage | $6,614.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $234,656.65 | 2022-2025 | Botox, Natrelle Saline-Filled Breast Implants |
| Allergan, INC. | $96,463.07 | 2019-2022 | |
| Galderma Laboratories, L.P. | $16,854.62 | 2019-2025 | |
| Apyx Medical Corporation | $487.00 | 2019-2020 | |
| Mentor Worldwide LLC | $95.81 | 2019-2022 | |
| Merz North America, INC. | $76.35 | 2021 | |
| Inspire Medical Systems, INC. | $24.73 | 2024 | Inspire |
| Motiva USA, LLC | $14.69 | 2025 | |
| Revance Therapeutics, INC. | $14.56 | 2024 | Daxxify |
| Aclaris Therapeutics, INC. | $14.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.